Skip to main content
. 2022 Apr 20;32(10):6777–6787. doi: 10.1007/s00330-022-08705-7

Fig. 3.

Fig. 3

Treatment strategy for advanced hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT)–related symptomatic portal hypertension to improve survival. A transjugular intrahepatic portosystemic shunt (TIPS) is used to resolve portal hypertension complications, including variceal bleeding, refractory ascites or hydrothorax, and access to antitumour treatment opportunities (molecular targeted agents)